RAPID DISPATCH
24/H dispatch
5 in stock
XELA REDERM 1,1% is a preparation based on non-stabilised hyaluronic acid and succinic acid, developed for the redermalisation procedure. It is indicated for the prevention of skin ageing and for improving the signs of dull, tired skin.
Its formulation promotes deep hydration, stimulates the proliferation of fibroblasts and contributes to improved elasticity, firmness and overall skin quality, giving the face a fresher, more vital appearance.
USE MEDICAL STRICT. Medical device. Use reserved for dermatologists and aesthetic doctors because they require a medical procedure.
skin.[/faq5]
XELA REDERM 1.1% 2ML is a solution:
- Indicated for patients between the ages of 28 and 35.
- For the redermisation procedure and improvement of skin quality.
- Promotes deep hydration and rebalancing of skin metabolism.
- It stimulates fibroblast proliferation and collagen synthesis.
- Helps improve elasticity, firmness and radiance of the skin.
- HYALUAL
- NAME: XELA REDERM 1.1% 2ML
- COMPOSITION: High molecular weight hyaluronic acid 1.1%, succinic acid 1.6%.
- PRESENTATION: 1 x 2 ml.
- NEEDLES: 2 x 30Gx13mm.
- INDICATIONS: Lymphatic drainage of the dermis. Reduction of the oedematous component. Improvement of microcirculation. Tissue detoxification. Lightening of the skin to 1-2 tones. Lightening of dark circles under the eyes. Elimination of signs of fatigue.
- INJECTION DEPTH: Superficial or medium-superficial intradermal injection. Recommended technique: papules.
- DURATION: For optimal results, a cycle of 3-5 sessions, spaced 1-2 weeks apart, is recommended.
- USE: Strict medical use.
- Syringe: 1 x 2 ml.
- Needles: 2 x 30Gx13mm.
Face, neck, décolleté and hands.
High molecular weight hyaluronic acid 1.1%, succinic acid 1.6%.
- The product must only be used by qualified medical personnel experienced in aesthetic medicine.
- Carry out a thorough patient history before treatment, assessing allergies, current therapies and clinical conditions.
- Use strict aseptic techniques and sterile disposable material.
- Avoid administration in areas recently treated with other injectable devices, unless medically assessed.
- Do not mix the product with other substances or drugs not expressly indicated.
- Inform the patient of the possible occurrence of transient local reactions (redness, oedema, slight pain or a feeling of tension).
- After treatment, avoid exposure to intense heat, UV radiation, vigorous massage or intense physical activity for the period indicated by the doctor.
XELA REDERM 1,1% 2ML is contraindicated in the following cases:
- Known hypersensitivity or allergy to hyaluronic acid, succinic acid or any of the components of the product.
- Presence of active skin infections, inflammation, dermatitis or lesions in the area to be treated.
- Active autoimmune diseases or uncontrolled conditions of immunodepression.
- Pregnancy and lactation.
- Previous significant adverse reactions to hyaluronic acid-based injectable treatments.
- Clotting disorders or unstabilised anticoagulant therapy.
- Patients below the age stipulated in the device indications.
Indicated for dry skin, uneven skin relief, small wrinkles and signs of photo-ageing.
XELA REDERM 1.1% is an injectable medical device based on non-stabilised hyaluronic acid and succinic acid, designed for redermalisation. Its main objective is to prevent skin ageing and improve the appearance of dull, tired skin, without creating volume.
It is especially indicated for young-adult patients, generally between the ages of 28 and 35, who have dry skin, a dull complexion, the first signs of photoageing or loss of radiance and wish to improve the quality of their skin in a natural way.
XELA REDERM 1,1% promotes lymphatic drainage of the dermis and improved skin microcirculation, helping to reduce the oedematous component, detoxify the tissues and lighten the skin, including the eye area with a reduction in the appearance of dark circles.
The treatment can be carried out on the face, neck, décolleté and hands, areas particularly prone to dehydration, oxidative stress and the first signs of skin ageing.
For optimal results, a cycle of 3-5 sessions, performed 1-2 weeks apart, is recommended. The protocol can be customised by the doctor according to the skin condition and the patient's goals.